Chester County News and Community Website
LANGHORNE, PA — TEN Holdings Inc. (Nasdaq: XHLD) reported a decline in revenue and a wider net loss for fiscal year 2025 as the company incurred higher expenses tied to …
TEN Holdings Reports 2025 Revenue Decline, Wider Net Loss Read More
BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) reported fourth-quarter and full-year 2025 financial results while advancing its lead candidate nomlabofusp toward a planned FDA filing for the treatment …
Larimar Reports Results, Advances Nomlabofusp Toward FDA Filing Read More
PHILADELPHIA, PA — Five Below, Inc. (Nasdaq: FIVE) reported higher net sales and earnings for the fourth quarter and full year of fiscal 2025, driven by comparable sales growth and …
Five Below Reports Q4, Full-Year 2025 Sales and Earnings Growth Read More
MALVERN, PA — Neuronetics, Inc. (Nasdaq: STIM) reported higher fourth-quarter and full-year 2025 revenue, narrowed its losses, posted positive operating cash flow in the fourth quarter, and said Dan Reuvers …
Neuronetics Reports Higher Revenue, Narrows Loss, Sets 2026 Outlook Read More
DOYLESTOWN, PA — Aprea Therapeutics Inc. (Nasdaq: APRE) reported its fourth-quarter and full-year 2025 financial results and said early clinical data from its ongoing Phase 1 trial of APR-1051 showed …
Aprea Reports 2025 Results, Early Data for APR-1051 Trial Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) reported its 2025 financial results and said it advanced late-stage clinical development of its investigational drug buntanetap, including launching a Phase 3 …
Annovis Reports 2025 Results, Advances Buntanetap Trials Read More
WAYNE, PA — Trinseo (NYSE: TSE) reported a fourth-quarter 2025 net loss of $251 million and a full-year net loss of $546 million, driven by lower sales volumes, pricing pressure, …
Trinseo Reports 2025 Loss as Sales Decline and Restructuring Costs Rise Read More
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) reported fourth-quarter and full-year 2025 financial results while advancing its MOLBREEVI program, including a filed Biologics License Application with the U.S. Food and …
Savara Reports 2025 Results, Advances MOLBREEVI Toward Approval Read More
READING, PA — Cambridge-Lee Holdings, Inc. reported increased revenue and net income for the fourth quarter of 2025, driven by higher sales and operating income, according to unaudited results released …
Cambridge-Lee Reports Higher Revenue and Net Income in Q4 2025 Read More
PLYMOUTH MEETING, PA — INOVIO (Nasdaq: INO) reported its 2025 financial results and said the U.S. Food and Drug Administration is reviewing its lead drug candidate, INO-3107, for a rare …
INOVIO Reports 2025 Results as FDA Reviews Lead Drug Candidate Read More